Introduction {#s1}
============

Type 1 diabetes is generally caused by autoimmune destruction of insulin-producing β-cells in the pancreas of genetically susceptible subjects. The most important genes contributing to disease susceptibility are located in the human leukocyte antigen (HLA) class II locus on the short arm of chromosome 6. Several environmental factors have also been implicated in the pathogenesis of this disease ([@r1],[@r2],[@r3]).

Detection of autoantibodies, such as those to insulin (IAA), glutamic acid decarboxylase (GADA) and the protein tyrosine phosphatase-related molecule IA-2 (IA-2A), provides useful markers for diagnosis of type 1 diabetes. Over 80% of patients with newly diagnosed type 1 diabetes have GADA, 70% have IA-2A and approximately 60% have IAA ([@r1]). However, a few cases have no evidence of β-cell autoimmunity despite absolute insulin deficiency, a form of the disease classified as idiopathic, non-immune mediated, type 1 diabetes ([@r4], [@r5]).

Numerous genetic studies have demonstrated associations of HLA class II variants with type 1 diabetes. In Caucasian populations, the *DRB1*\**0405*/\**0401*-*DQB1*\**0302* and *DRB1*\**0301*-*DQB1*\**0201* genotypes are positively correlated with type 1 diabetes, and the former genotype is significantly more strongly predisposing than the latter ([@r6]). In the Japanese population, however, the *DRB1*\**0301*-*DQB1*\**0201* genotype is rare in both patients and the general population, whereas the *DRB1*\**405*-*DQB1*\**0401* and *DRB1*\**0901*-*DQB1*\**0303* genotypes are positively correlated with type 1 diabetes ([@r7], [@r8]). Moreover, Kawabata *et al*. ([@r8]) reported that the *DRB1*\**405*-*DQB1*\**0401* genotype is more strongly associated with disease susceptibility than the *DRB1*\**0901*-*DQB1*\**0303* genotype because the presence of the former genotype alone confers susceptibility to type 1 diabetes, whereas homozygous presence of the latter is only associated with development of the disease ([@r8]). Furthermore, Sugihara *et al*. ([@r9]) reported that the *DRB1*\**0901*-*DQB1*\**0303* genotype induces stronger autoimmune destructive responses against β-cells than the *DRB1*\*405-*DQB1*\**0401* genotype in childhood-onset cases.

On the other hand, several studies have shown that the pathogenic characteristics in young children with type 1 diabetes differ from those in older children as well as adults. Several studies have reported decreased prevalences of some of the diabetes-related autoantibodies at diagnosis in young children compared with those in cases with later onset ([@r10],[@r11],[@r12],[@r13]). In regard to genetic background, several studies have revealed different frequencies of some diabetes-related HLA alleles and haplotypes in young children compared with those in older children and adults ([@r9], [@r10], [@r12], [@r14], [@r15]).

These findings suggest that pathogenic characteristics in young children with type 1 diabetes could differ from those in older cases. However, little is known about the genetic background or β-cell autoimmunity status of young children with type 1 diabetes in Japan. We studied the pathogenic characteristics at diagnosis of Japanese children with type 1 diabetes presenting prior to 5 yr of age.

Materials and Methods {#s2}
=====================

Subjects
--------

The study subjects were 23 Japanese children, 9 males and 14 females, with type 1 diabetes residing in the Kanto district of Japan. They were diagnosed as having the disease prior to 5 (1.1--4.8) yr of age during the period from 1995 to 2005. They exhibited typical symptoms of diabetes, and 20 out of 23 (87.0%) presented with ketoacidosis (pH\<7.3 and HCO~3~--\<15.0 mmol/L) and/or impaired consciousness as the initial manifestation of the disease. The mean plasma glucose and HbA1c values at diagnosis were 556 ± 121 (362--784) mg/dl and 10.8 ± 2.2 (7.5--14.8) %, respectively. The mean serum C-peptide level was 0.25 ± 0.25 (undetectable-0.8) ng/ml at diagnosis. In regard to family history of diabetes, one patient had an affected father with type 1 diabetes, but none of the patients had any first-degree relatives with type 2 diabetes.

Methods
-------

We evaluated the prevalence of GADA and IA-2A in 19 and 17 of the 23 young children, respectively, at the time of diagnosis and determined the HLA class II genes in all the subjects.

GADA and IA-2A were determined by radioimmunoassay (Cosmic Corporation, Tokyo, Japan). The cut-off limits for GADA and IA-2A antibody positivity were 1.5 U/ml and 0.4 U/ml, respectively. The frequencies of these two antibodies were compared with the results for 51 children, 21 males and 30 females, with later onset of type 1 diabetes. These children also initially exhibited typical symptoms of hyperglycemia and/or presented with ketoacidosis, but they were more than 5 (7.1--14.8) yr of age at diagnosis.

HLA-DR and DQ genes were analyzed using a polymerase chain reaction (PCR)-sequencing-based typing (SBT) method \[SRL, Inc., Tokyo, Japan\] ([@r16]). Informed consent for analysis of HLA-DR and DQ genes was obtained from the patients' parents. This study was approved by the ethical committee of our institution.

The frequencies of viral infections prior to the onset of diabetes was also investigated in all subjects. Preceding viral infection was estimated by the presence of symptoms such as pyrexia and sore throat more than 3 mo prior to the onset of diabetes and/or by elevation of IgM class antibody-titers against viruses in sera.

Statistical analysis
--------------------

The results were expressed as means ± SD. To detect differences in frequencies between two groups, the chi-square test was applied, and p\<0.05 was considered to indicate a statistically significant difference.

Results {#s3}
=======

Prevalences of GADA and IA-2A at the time of diagnosis
------------------------------------------------------

We examined the prevalences of β-cell antibodies, GADA and IA-2A, at the time of diagnosis in children with type 1 diabetes who were younger than 5 years at diagnosis. The prevalence of GADA was 31.6% (6/19), and that of IA2-A was 47.1% (8/17). On the other hand, among the 51 children with later onset of type 1 diabetes diagnosed after 5 yr of age, the prevalence of GADA was 86.3% (44/51), and that of IA-2A was 82.5% (33/40). Thus, the prevalences of both GADA and IA-2A were significantly decreased in the young children compared with the children with later-onset (p\<0.0001 and p=0.0064, respectively).

In respect to the titers of GADA and IA-2A, the mean titer of GADA was 9.62 ± 19.33 U/ml and that of IA-2A was 2.64 ± 4.13U/ml in the young children.

Frequencies of HLA class II alleles
-----------------------------------

Frequencies of *HLA*-*DRB1* alleles: [Table 1](#tbl_001){ref-type="table"}Table 1.Frequencies of *HLA*-*DRB1* alleles in children with type 1 diabetes who were younger than 5 yr of age at diagnosis shows the frequencies of *HLA*-*DRB1* alleles in the young children. The allele frequency of *DRB1*\**0405* was 73.9%, and that of *DRB1*\**0901* was 47.8%. The young children had significantly higher frequencies of *DRB1*\**0405* (p\<0.0001) and *DRB1*\**0901* (p\<0.0001) than the control subjects ([@r8]). Moreover, all subjects had one of the high-risk *HLA*-*DRB1* alleles. On the other hand, the allele frequency of *DRB1*\**0405*/\**0405* was 34.8%, that of *DRB1*\**0405*/\**0901* was 17.4% and that of *DRB1*\**0901*/\**0901* was 21.7%. These results demonstrated that homozygous or compound heterozygous presence of the high-risk *HLA*-*DRB1* alleles was frequent in the young children. Furthermore, none of the patients had any protective *HLA*-*DRB1* genotypes.

Frequencies of HLA-*DQB1* alleles: [Table 2](#tbl_002){ref-type="table"}Table 2.Frequencies of HLA-*DQB1* alleles in children with type 1 diabetes who were younger than 5 yr of age at diagnosis shows the frequencies HLA-*DQB1* alleles in the young children. The allele frequency of *DQB1*\**0401* was 39.1%, and that of *DQB1*\**0303* was 52.2%. The young children had significantly higher frequencies of *DQB1*\**0401* (p=0.0173) and *DQB1*\**0303* (p\<0.0001) than the control subjects ([@r8]). All subjects also had one of the high-risk HLA-*DQB1* alleles. On the other hand, the allele frequency of *DQB1*\**0303*/\**0303* was 21.7%, that of *DQB1*\**0303*/\**0401* was 17.4% and that of *DQB1*\**0401*/\**0401* was 13.0%. These results also demonstrated that homozygous or compound heterozygous presence of the high-risk HLA-*DQB1* alleles was frequent in the young children. Similar to the results for the *HLA*-*DRB1* alleles, none of the patients had any protective *HLA*-*DQB1* genotypes.

Frequencies of *HLA*-*DRB1* and *DQB1* haplotypes
-------------------------------------------------

[Table 3](#tbl_003){ref-type="table"}Table 3.Frequencies of *HLA*-*DQB1* and *DQB1* haplotypes in children with type 1 diabetes who were younger than 5 yr of age at diagnosis shows the frequencies *HLA*-*DRB1* and *DQB1* haplotypes in the young children. The frequency of homozygous or heterozygous presence of *DRB1\*0405*-*DQB1*\**0401* was 60.9%, and that of *DRB1\*0901*/*DQB1*\**0303* was 57.2%. The heterozygous frequencies of the presence of *DRB1\*0405*-*DQB1*\**0401* and *DRB1\*0901*/*DQB1*\**0303* were 34.8% and 21.7%, respectively, whereas the homozygous frequencies of these high-risk haplotypes were 8.7% and 13.0%, respectively. The young children had significantly higher frequencies of homozygous presence of *DRB1\*0901*/*DQB1*\**0303* (21.7%, p=0.0026) and genotypic combination of the two high risk alleles (p=0.0303) compared with the control subjects ([@r8]). Only one patient (4.3%) had neither of the high-risk haplotypes, which was significantly less frequent than in the control subjects (p\<0.0001) ([@r8]).

Frequencies of viral infections prior to disease onset
------------------------------------------------------

We examined the frequencies of viral infections prior to the onset of diabetes. Ten of the 23 patients (43.5%) had symptoms of viral illness before more than 3 mo prior to the onset of diabetes and/or had elevated IgM class antibodies against viruses, i.e., three cases with influenza viruses, two cases with coxsackie B viruses, one case with a mumps virus, one case with a respiratory syncytial virus and four cases with unknown viral origins.

Discussion {#s4}
==========

The pathogenic characteristics of young children with type 1 diabetes could be different from those of older children as well as adults. Several studies have demonstrated lower prevalences of some diabetes-related autoantibodies in young-onset cases. Hathout *et al*. ([@r10]) reported that the prevalences of islet-cell antibodies (ICA) and GADA were decreased in young children diagnosed before 5 yr of age compared with those of older children. Feeney *et al*. ([@r11]) reported lower frequencies of GADA and IA-2A in young children diagnosed before 5 yr of age than in older children. Komulainen *et al*. ([@r12]) reported that very young children less than 2 yr of age had the lowest titers of IA-2A among pediatric cases with type 1 diabetes. In the present study, we found significantly lower prevalences of both GADA and IA-2A at diagnosis in young children presenting prior to 5 yr of age than in older cases. These findings indicate that the prevalences of GADA and IA-2A are possibly decreased in children diagnosed in early childhood.

Most studies on diabetes-related autoantibodies have shown a higher prevalence of IAA at diagnosis in young children than in adolescents and adults ([@r11],[@r12],[@r13], [@r17], [@r18]). The early appearance of IAA is usually followed by autoantibodies to other β-cell antigens such as GAD and IA-2 ([@r17], [@r16]). Unfortunately, we were unable to examine IAA because of technical difficulties with antibody measurement. It is probable that our subjects might have had a high frequency of IAA at diagnosis despite the low prevalences of GAD and IA-2A.

The absence of diabetes-related autoantibodies in these young children at the time of diagnosis suggests that mechanisms other than autoimmunity lead to destruction of pancreatic β-cells. One possible mechanism involves viral infections via a direct cytotoxic effect on β-cells. We found that viral infections prior to the onset of diabetes were frequent in young children. Hathout *et al*. ([@r10]) also reported a high frequency of preceding viral illness among children with young-onset diabetes. Several studies have shown that certain viruses are capable of inducing diabetes in experimental animals ([@r1], [@r2]). Another hypothesis involves rapid progression of β-cell autoimmunity in young-onset childhood diabetes. It is possible that immune-mediated β-cell destruction develops rapidly and that β-cell autoantibodies have already disappeared prior to clinical diagnosis. Consequently, we could not find diabetes-related autoantibodies in sera at the time of diagnosis.

Sugihara *et al*. ([@r9]) reported that that *DRB1*\**0901*-*DQB1*\**0303* is more common in children with early-onset (0--5 yr of age) diabetes, whereas *DRB1*\**405*-*DQB1*\**0401* is more frequently detected in late-onset cases (11--16 yr of age) among Japanese children with type 1 diabetes. Ohtsu *et al*. also ([@r15]) reported a higher frequency of *DRB1*\**0901*-*DQB1*\**0303* in young-onset cases than in late-onset and slowly progressive cases. However, we found the prevalences of these two high-risk HLA class II genotypes, which were more frequent than those in the older cases, to be equal. Furthermore, no young children had any protective genotypes for either HLA-DR or -DQ alleles. From these findings, strong HLA-defined disease susceptibility may induce severe destruction of pancreatic β-cells early in life in patients with early-onset type 1 diabetes. Rapid autoimmune and/or non-immune mediated β-cell destruction develop prior to clinical diagnosis of the disease. However, the number of subjects used in the present study was too small to reach a conclusion. Other previous studies have demonstrated data that is different fro our results ([@r9], [@r15]). Father accumulation of data is required in regard to HLA genotypes and haplotypes in young children with type 1 diabetes in the Japanese population. Caucasian studies have demonstrated HLA genotypes associated with disease-susceptibility to be more frequent in young children, whereas the proportion of children carrying a genotype including protective alleles is higher among the older cases ([@r10], [@r12]).

In conclusion, the children diagnosed with type 1 diabetes before 5 yr of age had decreased prevalences of diabetes-related autoantibodies, but had high frequencies of viral infections prior to disease onset. Furthermore, strong disease susceptibility conferred by HLA class II genes was evident in these young children. Early-childhood onset cases may have diabetes-related autoimmunity and genetic backgrounds different from those of patients diagnosed at a later age.
